These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 19707857)
1. KLF6 inhibits estrogen receptor-mediated cell growth in breast cancer via a c-Src-mediated pathway. Liu J; Du T; Yuan Y; He Y; Tan Z; Liu Z Mol Cell Biochem; 2010 Feb; 335(1-2):29-35. PubMed ID: 19707857 [TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells. Fox EM; Bernaciak TM; Wen J; Weaver AM; Shupnik MA; Silva CM Mol Endocrinol; 2008 Aug; 22(8):1781-96. PubMed ID: 18550772 [TBL] [Abstract][Full Text] [Related]
3. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance. Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644 [TBL] [Abstract][Full Text] [Related]
4. Nuclear expression of KLF6 tumor suppressor factor is highly associated with overexpression of ERBB2 oncoprotein in ductal breast carcinomas. Gehrau RC; D'Astolfo DS; Dumur CI; Bocco JL; Koritschoner NP PLoS One; 2010 Jan; 5(1):e8929. PubMed ID: 20126619 [TBL] [Abstract][Full Text] [Related]
5. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma. Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523 [TBL] [Abstract][Full Text] [Related]
6. Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells. Guo H; Lin Y; Zhang H; Liu J; Zhang N; Li Y; Kong D; Tang Q; Ma D BMC Mol Biol; 2007 Dec; 8():110. PubMed ID: 18053161 [TBL] [Abstract][Full Text] [Related]
7. miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation. Zhang D; Li Z; Zhang Y; Tu C; Huo J; Liu Y Oncol Rep; 2016 Dec; 36(6):3657-3663. PubMed ID: 27779691 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines. Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1. Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706 [TBL] [Abstract][Full Text] [Related]
10. Mutations and Krüppel-like factor 6 (KLF6) expression levels in breast cancer. Ozdemir F; Koksal M; Ozmen V; Aydin I; Buyru N Tumour Biol; 2014 Jun; 35(6):5219-25. PubMed ID: 24519062 [TBL] [Abstract][Full Text] [Related]
11. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src. Liu H; Qiu J; Li N; Chen T; Cao X J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377 [TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor activity of KLF6 mediated by downregulation of the PTTG1 oncogene. Lee UE; Ghiassi-Nejad Z; Paris AJ; Yea S; Narla G; Walsh M; Friedman SL FEBS Lett; 2010 Mar; 584(5):1006-10. PubMed ID: 20116377 [TBL] [Abstract][Full Text] [Related]
14. KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis. Narla G; DiFeo A; Fernandez Y; Dhanasekaran S; Huang F; Sangodkar J; Hod E; Leake D; Friedman SL; Hall SJ; Chinnaiyan AM; Gerald WL; Rubin MA; Martignetti JA J Clin Invest; 2008 Aug; 118(8):2711-21. PubMed ID: 18596922 [TBL] [Abstract][Full Text] [Related]
15. Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer. Lee K; Liu Y; Mo JQ; Zhang J; Dong Z; Lu S BMC Cancer; 2008 Jun; 8():158. PubMed ID: 18518979 [TBL] [Abstract][Full Text] [Related]
16. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival. Hatami R; Sieuwerts AM; Izadmehr S; Yao Z; Qiao RF; Papa L; Look MP; Smid M; Ohlssen J; Levine AC; Germain D; Burstein D; Kirschenbaum A; DiFeo A; Foekens JA; Narla G Sci Transl Med; 2013 Jan; 5(169):169ra12. PubMed ID: 23345610 [TBL] [Abstract][Full Text] [Related]
17. GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21. Lang UE; Kocabayoglu P; Cheng GZ; Ghiassi-Nejad Z; Muñoz U; Vetter D; Eckstein DA; Hannivoort RA; Walsh MJ; Friedman SL Oncogene; 2013 Sep; 32(38):4557-64. PubMed ID: 23085750 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of estrogen receptor α-36 by breast cancer oncogene IKKε promotes growth of ER-negative breast cancer cells. Li Q; Sun H; Zou J; Ge C; Yu K; Cao Y; Hong Q Cell Physiol Biochem; 2013; 31(6):833-41. PubMed ID: 23816933 [TBL] [Abstract][Full Text] [Related]
19. Alterations in c-Src/HER1 and estrogen receptor α signaling pathways in mammary gland and tumors of hexachlorobenzene-treated rats. Peña D; Pontillo C; García MA; Cocca C; Alvarez L; Chiappini F; Bourguignon N; Frahm I; Bergoc R; Kleiman de Pisarev D; Randi A Toxicology; 2012 Mar; 293(1-3):68-77. PubMed ID: 22245120 [TBL] [Abstract][Full Text] [Related]
20. TGF-beta regulates the expression of transcription factor KLF6 and its splice variants and promotes co-operative transactivation of common target genes through a Smad3-Sp1-KLF6 interaction. Botella LM; Sanz-Rodriguez F; Komi Y; Fernandez-L A; Varela E; Garrido-Martin EM; Narla G; Friedman SL; Kojima S Biochem J; 2009 Apr; 419(2):485-95. PubMed ID: 19076057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]